Mannkind (MNKD) Change in Account Payables (2010 - 2026)
Mannkind (MNKD) reported Change in Account Payables of $7.1 million for Q1 2026, up 506.05% year-over-year from $1.2 million in Q1 2025, and up 141.37% quarter-over-quarter from -$17.2 million in Q4 2025.
Mannkind (MNKD) Change in Account Payables (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Change in Account Payables data on file, last reported at $7.1 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $7.1 million, up 506.05% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.8 million (down 272.39% YoY), and the FY2025 annual result was -$16.7 million, down 499.39% from the prior year.
- Change in Account Payables improved to $7.1 million in Q1 2026 per MNKD's latest filing, from -$17.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $7.1 million in Q1 2026 and troughed at -$17.2 million in Q4 2025.
- A 5-year average of -$574470.6 and a median of $348000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables sank 5039.08% in 2025, then soared 506.05% in 2026.
- A 5-year view of Change in Account Payables shows it stood at $1.2 million in 2022, then slumped by 708.05% to -$7.2 million in 2023, then jumped by 104.85% to $348000.0 in 2024, then slumped by 5039.08% to -$17.2 million in 2025, then soared by 141.37% to $7.1 million in 2026.
- Business Quant data shows MNKD's Change in Account Payables at $7.1 million in Q1 2026, -$17.2 million in Q4 2025, and -$3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -9.42 Mn |
| 10 | Mannkind | 1.13 Bn | 995.19 Mn | 82.66 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.11 Mn |
| Mar 31, 2026 | 7.11 Mn |
| Dec 31, 2025 | -17.19 Mn |
| Dec 31, 2025 | -17.19 Mn |
| Sep 30, 2025 | -2.99 Mn |
| Sep 30, 2025 | -2.99 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Mar 31, 2025 | -1.75 Mn |
| Mar 31, 2025 | -1.75 Mn |
| Dec 31, 2024 | 348,000.00 |
| Dec 31, 2024 | 348,000.00 |
| Sep 30, 2024 | -3.11 Mn |
| Sep 30, 2024 | -3.11 Mn |
| Jun 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 2.41 Mn |
| Mar 31, 2024 | -2.43 Mn |
| Mar 31, 2024 | -2.43 Mn |
| Dec 31, 2023 | -7.18 Mn |
| Dec 31, 2023 | -7.18 Mn |